Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Autoimmune Diseases × CNS × Clear all

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 4 Other hematologic neoplasm 3 Plasma cell 2 Genitourinary 2 Thoracic 1 Myeloid 1 Gynecologic 1 Classical hematology 1 CNS 1 Breast 1

Conditions

Brain Neoplasms 947 Glioblastoma 822 Glioma 541 Central Nervous System Neoplasms 396 Astrocytoma 355 Gliosarcoma 312 Neuroblastoma 294 Oligodendroglioma 229 Neoplasms 168 Medulloblastoma 147 Breast Neoplasms 134 Sarcoma 101 Ependymoma 100 Recurrence 94 Neoplasm Metastasis 86 Meningioma 84 Carcinoma, Non-Small-Cell Lung 79 Melanoma 78 Lymphoma 76 Neurofibromatosis 1 71 Precursor Cell Lymphoblastic Leukemia-Lymphoma 70 Wilms Tumor 69 Lung Neoplasms 68 Osteosarcoma 63 Lymphoma, Non-Hodgkin 61 Head and Neck Neoplasms 60 Ovarian Neoplasms 59 Burkitt Lymphoma 59 Testicular Neoplasms 57 Familial ependymoma 55

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00806182 2017-05-23

OMS

National Pediatric Neuroinflammation Organization, Inc.

Ataxia, Autoimmune Diseases, Neuroblastoma, Opsoclonus-Myoclonus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡